Quidel Provides Business Update at 13th Annual Piper Sandler Med-Tech and Diagnostic California Bus Tour; Another SARS Antigen Entrant Does Not Change Quidel’s StrategyBusiness Wire • 08/27/20
Quidel to Present Today at 13th Annual Piper Sandler Med-Tech and Diagnostics California Bus TourBusiness Wire • 08/27/20
Quidel to Update Packaging of Point-of-Care Sofia® SARS Antigen Test for COVID-19 to Include Either Nasal or Nasopharyngeal SwabsBusiness Wire • 08/20/20
National Study Finds Lyme Disease 10 Times Greater Than Reported to CDC; Quidel-Sponsored Webinar Reveals Prevalence and Patterns of Lyme DiseaseBusiness Wire • 08/19/20
It’s Lyme Disease Season: ‘Be on Guard and Get Tested’ Says Leading Health Solutions Developer Quidel CorporationBusiness Wire • 08/11/20
State of Maryland Allows Point-of-Care Testing for COVID-19; Quidel Expands Training ProgramBusiness Wire • 08/10/20
Quidel Receives Preliminary Contract Leading to Definitive Agreement for $71 Million Under NIH’s RADx-ATP Program to Accelerate the Expansion of Its Manufacturing Capacity for Sofia® SARS-CoV-2 Antigen Detection Test for Rapid Diagnosis of COVID-19Business Wire • 07/31/20
Quidel Corporation (QDEL) CEO Peter Ingram on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 07/31/20
CORRECTING and REPLACING Quidel to Present Virtually at the Canaccord Genuity 40th Annual Growth ConferenceBusiness Wire • 07/29/20